ImmunoPrecise Antibodies Analyst Ratings
ImmunoPrecise Antibodies Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/18/2023 | 411.36% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 07/12/2023 | 411.36% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 07/11/2023 | 297.73% | Benchmark | → $7 | Reiterates | Speculative Buy → Speculative Buy |
| 03/21/2023 | 297.73% | Benchmark | $12 → $7 | Maintains | Speculative Buy |
| 03/17/2023 | 411.36% | HC Wainwright & Co. | → $9 | Reiterates | → Buy |
| 12/02/2022 | 411.36% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 10/25/2021 | 581.82% | Benchmark | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/18/2023 | 411.36% | HC Wainwright公司 | →$9 | 重申 | 購買→購買 |
| 07/12/2023 | 411.36% | HC Wainwright公司 | →$9 | 重申 | 購買→購買 |
| 07/11/2023 | 297.73% | 基準 | →$7 | 重申 | 投機性買入→投機性買入 |
| 03/21/2023 | 297.73% | 基準 | $12→$7 | 維護 | 投機性購買 |
| 03/17/2023 | 411.36% | HC Wainwright公司 | →$9 | 重申 | →購買 |
| 12/02/2022 | 411.36% | HC Wainwright公司 | →$9 | 開始承保 | →購買 |
| 2021年10月25日 | 581.82% | 基準 | →$12 | 開始承保 | →購買 |
What is the target price for ImmunoPrecise Antibodies (IPA)?
免疫精製抗體(IPA)的目標價格是多少？
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by HC Wainwright & Co. on September 18, 2023. The analyst firm set a price target for $9.00 expecting IPA to rise to within 12 months (a possible 411.36% upside). 6 analyst firms have reported ratings in the last year.
免疫精製抗體(納斯達克代碼：IPA)的最新目標價是由HC Wainwright&Co.於2023年9月18日報告的。這家分析公司將目標價定為9美元，預計IPA將在12個月內上漲至(可能上漲411.36%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for ImmunoPrecise Antibodies (IPA)?
免疫純化抗體(IPA)的最新分析師評級是多少？
The latest analyst rating for ImmunoPrecise Antibodies (NASDAQ: IPA) was provided by HC Wainwright & Co., and ImmunoPrecise Antibodies reiterated their buy rating.
對免疫精製抗體(納斯達克代碼：IPA)的最新分析師評級由HC Wainwright&Co.提供，免疫精製抗體重申其買入評級。
When is the next analyst rating going to be posted or updated for ImmunoPrecise Antibodies (IPA)?
下一次分析師評級將於何時發佈或更新免疫精製抗體(IPA)？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ImmunoPrecise Antibodies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ImmunoPrecise Antibodies was filed on September 18, 2023 so you should expect the next rating to be made available sometime around September 18, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與免疫精準抗體的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。免疫精製抗體的上一次評級是在2023年9月18日提交的，所以你應該預計下一次評級將在2024年9月18日左右的某個時候提供。
Is the Analyst Rating ImmunoPrecise Antibodies (IPA) correct?
分析師對免疫精確度抗體(IPA)的評級正確嗎？
While ratings are subjective and will change, the latest ImmunoPrecise Antibodies (IPA) rating was a reiterated with a price target of $0.00 to $9.00. The current price ImmunoPrecise Antibodies (IPA) is trading at is $1.76, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的免疫精製抗體(IPA)評級被重申，目標價在0.00美元到9.00美元之間。目前免疫精製抗體(IPA)的交易價格為1.76美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。